According to the Zhitong Finance App, Chengda Pharmaceutical (301201.SZ) released its report for the first quarter of 2024. The company's revenue was 101 million yuan, a year-on-year decrease of 1.28%. Net profit attributable to shareholders of listed companies was 18.6445 million yuan, a year-on-year decrease of 5.09%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 10.2459 million, a year-on-year decrease of 26.77%. Basic earnings per share were $0.1215.
诚达药业(301201.SZ)发布一季度业绩，净利润1864.45万元，下降5.09%
Chengda Pharmaceutical (301201.SZ) announced first-quarter results, net profit of 18.644,500 yuan, a decrease of 5.09%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated